Trade Summary

1 week ago, Moatazedi David, serving as See Remarks at Evolus, Inc. (EOLS), sold 10,539 shares at $7.15 per share, for a total transaction value of $75,361.00. Following this transaction, Moatazedi David now holds 354,388 shares of EOLS.

This sale represents a 3.00% decrease in Moatazedi David's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Monday, December 22, 2025 and publicly disclosed via SEC Form 4 filing on Monday, December 29, 2025, 7 days after the trade was made.

Evolus, Inc. operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.